Medicine News and Research

RSS

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis.

19 Jan 2022

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.

19 Jan 2022

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

19 Jan 2022

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers at the University of Illinois Chicago.

19 Jan 2022

Novel robotic replica of human spine enables surgeons to preview the effects of surgery

Degenerative disc disease affects about 40 percent of people aged 40, increasing to about 80 percent among those aged 80 or older. The disease, which is the deterioration of one or more intervertebral discs of the spine, often is surgically treated with cervical disc implants.

19 Jan 2022

Waiting more than 5 hours in emergency care before admission may increase mortality risk

Waiting more than 5 hours in emergency care before admission to hospital is linked to a heightened risk of death from any cause within the next 30 days, reveals a study of more than 5 million patients in England and published online in the Emergency Medicine Journal.

19 Jan 2022

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

A growing body of evidence indicates that some people thought to have an allergic response to injectable penicillin, the standard treatment for rheumatic heart disease, may instead be experiencing a cardiac reaction to the medicine, according to a new American Heart Association presidential advisory published today in Journal of the American Heart Association.

19 Jan 2022

Study shows inequalities in addressing post-acute neurological manifestations of COVID-19

Researchers have explored the inequities in understanding and addressing the neurological complications of COVID-19 among marginalized communities in the United States.

19 Jan 2022

Research finds quick recovery of heart function in children with COVID-19-related MIS-C

Heart function recovery returned within three months in children who developed COVID-19-related multisystem inflammatory syndrome (MIS-C), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

19 Jan 2022

Performance of lateral flow tests for detecting SARS-CoV-2 in children falls short of minimum criteria

The performance of lateral flow (antigen) tests commonly used to detect COVID-19 infection in children falls short of the minimum criteria set by the World Health Organization (WHO) and US and UK device regulators, finds a pooled data analysis of the available evidence on 8 different tests, published in the journal BMJ Evidence-Based Medicine.

19 Jan 2022

Evaporators assist academic drug discovery

BioChromato Inc reports how the renowned Chemistry Research Laboratories (CRL) at Oxford University (UK) are using several Smart Evaporator C1 units to support their drug discovery activities in therapeutic areas including oncology and regenerative medicine.

From BioChromato Inc. 19 Jan 2022

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

In a new study, a team of researchers described the case of a healthy 49-year old male patient with new-onset atrial fibrillation after receiving the second dose of the COVID-19 mRNA-1273 (Moderna) vaccine.

19 Jan 2022

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours — a feat that's nearly unheard of in standard clinical care.

19 Jan 2022

Study finds variations in the magnitude and direction of sex differences in COVID-19 outcomes

A new study by the Harvard GenderSci Lab in Social Science and Medicine found large variations in the magnitude and direction of sex differences in COVID-19 outcomes across localities and over time during the pandemic in the U.S. -- demonstrating that observed sex disparities cannot be explained without reference to social-contextual factors.

19 Jan 2022

Machine learning model uses blood plasma proteins to predict survival for COVID-19 patients

A single blood sample from a critically ill COVID-19 patient can be analyzed by a machine learning model which uses blood plasma proteins to predict survival, weeks before the outcome, according to a new study published this week in the open-access journal PLOS Digital Health by Florian Kurth and Markus Ralser of the Charité – Universitätsmedizin Berlin, Germany, and colleagues.

19 Jan 2022

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers.

19 Jan 2022

Medicine News and Research

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

Novel robotic replica of human spine enables surgeons to preview the effects of surgery

Waiting more than 5 hours in emergency care before admission may increase mortality risk

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

Study shows inequalities in addressing post-acute neurological manifestations of COVID-19

Research finds quick recovery of heart function in children with COVID-19-related MIS-C

Performance of lateral flow tests for detecting SARS-CoV-2 in children falls short of minimum criteria

Evaporators assist academic drug discovery

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Study finds variations in the magnitude and direction of sex differences in COVID-19 outcomes

Machine learning model uses blood plasma proteins to predict survival for COVID-19 patients

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

Antibody combination produces a synergistic response in difficult-to-treat pediatric cancers

Early gender-affirming hormone therapy for transgender teens leads to better mental health

Porter Alliance for Innovative Medicines aims to close the gap between scientific research and clinical care

Schoolchildren in Hong Kong surveyed on the prevalence and impact of allergic diseases

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News